Skip to main content
Abliva logo

Abliva — Investor Relations & Filings

Ticker · ABLI ISIN · SE0002575340 LEI · 5493005YV22OTMUHZ183 ST Manufacturing
Open in API
Filings indexed 594 across all filing types
Latest filing 2025-03-03 Delisting Announcement
Country SE Sweden
Listing ST ABLI

About Abliva

https://abliva.com

Abliva is a biopharmaceutical company that discovers and develops medicines for the treatment of primary mitochondrial diseases. These are rare, congenital, and often severe genetic disorders that occur when the cell's energy converters, the mitochondria, are dysfunctional. The company's research and development is focused on creating novel therapies aimed at restoring mitochondrial function and addressing the significant unmet medical needs of patients. Abliva's primary goal is to deliver treatments that provide meaningful clinical benefits for individuals suffering from these debilitating conditions.

Recent filings

Filing Released Lang Actions
Delisting of the shares of Abliva: last day of trading 17 March 2025
Delisting Announcement Classification · 100% confidence The document explicitly announces the 'Delisting of the shares of Abliva' and specifies the 'last day of trading is on 17 March 2025'. This directly corresponds to the definition of a Delisting Announcement (Code: DLST). The document is short and serves as a formal notice of this corporate action.
2025-03-03 English
Avnotering av aktierna i Abliva: sista handelsdag 17 mars 2025
Delisting Announcement Classification · 99% confidence The document text is very short (836 characters) and explicitly announces the delisting ('Avnotering') of Abliva's shares from Nasdaq Stockholm, stating the last trading day will be March 17, 2025. This directly corresponds to the definition of a Delisting Announcement (DLST). The presence of a link to a PDF attachment further confirms this is a formal announcement of a specific corporate action rather than a comprehensive report.
2025-03-03 Swedish
Notice of Extraordinary General Meeting in Abliva AB (publ)
AGM Information Classification · 99% confidence The document is explicitly titled "Notice of Extraordinary General Meeting in Abliva AB (publ)". It details the date, time, location, preconditions for participation, proposed agenda items (including election of the Board of Directors), and proposals related to board composition and remuneration. This content directly relates to the formal proceedings and materials for a shareholder meeting, specifically an Extraordinary General Meeting (EGM). While it is a notice, the core purpose is to convene the meeting and present the items to be voted upon, which aligns closely with the scope of AGM-R (AGM Information), even though it is an EGM. Since there is no specific code for EGM, and the content is about the meeting itself (not just a proxy solicitation or voting results), AGM-R is the most appropriate classification among the choices provided, as it covers meeting materials. The document is substantial (7701 chars) and contains the full details, not just a brief announcement of publication.
2025-02-26 English
Kallelse till extra bolagsstämma i Abliva AB (publ)
AGM Information Classification · 99% confidence The document is explicitly titled 'Kallelse till extra bolagsstämma i Abliva AB (publ)', which translates to 'Notice of Extraordinary General Meeting in Abliva AB (publ)'. It details the date, location, registration procedures, and agenda for this meeting. The agenda includes items typical for a general meeting, such as electing the chairman, approving the agenda, and crucially, proposing changes to the board of directors (points 7-10) following a takeover bid. This content directly relates to the formal process and materials associated with a shareholder meeting, specifically an Extraordinary General Meeting (EGM). While the content discusses management changes (MANG) and voting results (DVA), the primary purpose and document type is the official summons to the meeting itself. This aligns best with the 'AGM Information' category, which covers presentations and materials shared during General Meetings (AGM/EGM).
2025-02-26 Swedish
Abliva applies for delisting and will convene an extraordinary general meeting
Delisting Announcement Classification · 100% confidence The document explicitly announces two major corporate actions: 1) Abliva applies for delisting of its shares from Nasdaq Stockholm, and 2) the Board will convene an Extraordinary General Meeting (EGM) at the request of the majority shareholder (Pharming). The delisting announcement directly corresponds to the definition for 'Delisting Announcement' (DLST). Although it mentions convening an EGM, the primary focus and most definitive action announced is the delisting application following a successful takeover bid. Since 'Delisting Announcement' is a specific category, it takes precedence over a general 'Regulatory Filing' (RNS). The document is short and acts as an announcement, not the full regulatory filing itself.
2025-02-25 English
Abliva ansöker om avnotering och kommer att kalla till extra bolagsstämma
Delisting Announcement Classification · 95% confidence The document text announces two key corporate actions: 1) Abliva is applying for delisting of its shares from Nasdaq Stockholm following a successful takeover bid by Pharming, and 2) Abliva will convene an Extraordinary General Meeting (EGM) on March 28, 2025, primarily for the election of a new board. The core subject matter relates to the consequences of a takeover (delisting) and the subsequent governance changes requiring a shareholder vote (EGM). Since the document explicitly mentions calling an EGM and the outcome of a takeover bid, it strongly relates to corporate control and shareholder meetings. However, the primary action announced is the delisting application, which directly corresponds to the 'Delisting Announcement' (DLST) category. The mention of calling an EGM is secondary to the delisting decision itself, which is the main news driver here. Given the explicit mention of 'ansöker om avnotering' (applies for delisting), DLST is the most precise fit, although it also touches upon AGM/EGM related activities.
2025-02-25 Swedish

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.